Boston Scientific, the Natick-based medical device giant, has received approval from the U.S. Food & Drug Administration for three of its cardiac defibrillators.
The company won approval for the Incepta, Energen and Punctua systems, which are all small in size to simplify the implant procedure to install them. The devices are used to prevent heart failure and sudden cardiac death.
Doctors installed the first version of one of the new defibrillators in a patient in Seattle on Tuesday.
